Showing results (31-40 of 295) with videos related to

Sort By:
Pageof 30
Age (Dordrecht, Netherlands)|May 9, 2014
Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus studyPetra G van Peet, Anton J M de Craen, Jacobijn Gussekloo, et al.
BMC Geriatrics|November 13, 2010
Diagnostic accuracy of plasma NT-proBNP levels for excluding cardiac abnormalities in the very elderlyBert Vaes, Victoria Delgado, Jeroen Bax, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 11, 2012
[Should subclinical hypothyroidism in older persons be treated?]Wendy P J den Elzen, Jan W A Smit, Simon P Mooijaart, et al.
Research in Social & Administrative Pharmacy : RSAP|November 15, 2018
The use of goal attainment scaling during clinical medication review in older persons with polypharmacySanne Verdoorn, Jeanet Blom, Timo Vogelzang, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 21, 2015
[Medication review in older people: identification of a new risk group]Loes C O C Tomaes, Rosalinde K E Poortvliet, Henk-Frans Kwint, et al.
Plos One|December 20, 2023
Association of low blood pressure and falls: An analysis of data from the Leiden 85-plus StudyDavid Röthlisberger, Katharina Tabea Jungo, Lukas Bütikofer, et al.
International Journal of Cardiology|December 13, 2005
Markers of autonomic tone on a standard ECG are predictive of mortality in old ageThomas van Bemmel, David J Vinkers, Peter W Macfarlane, et al.
Aging Clinical and Experimental Research|July 2, 2020
Clinical determinants of low handgrip strength and its decline in the oldest old: the Leiden 85-plus StudyCarolina H Y Ling, Jacobijn Gussekloo, Stella Trompet, et al.
BMC Geriatrics|March 21, 2021
Experiences with and attitudes towards geriatric screening among older emergency department patients: a qualitative studyLaura C Blomaard, Mareline Olthof, Yvette Meuleman, et al.
Basic & Clinical Pharmacology & Toxicology|December 28, 2025
A Clinical Medication Review Focused on Deprescribing in Older Patients With Hyperpolypharmacy: A Mixed-Methods Feasibility StudyGert Baas, Mette Heringa, Sanne Verdoorn, et al.
Pageof 30